SUMMIT MAX: A Randomized Trial of the Super Large Bore HiPoint Reperfusion System Versus Vecta System for Aspiration Thrombectomy

Overview of attention for article published in Stroke, May 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 24 X users

facebook: 1 Facebook page

Readers on

mendeley: 16 Mendeley

So far, Altmetric has seen 34 X posts from 24 X users, with an upper bound of 87,266 followers.

RT @StrokeAHA_ASA: #STROKE Simultaneous publication at #ESOC2025 🔴🔵 SUMMIT MAX trial showed that the super large bore HiPoint system was n…

RT @NguyenThanhMD: SUMMIT MAX: A randomized trial of the super large bore HiPoint Reperfusion System versus Vecta System for aspiration thr…

RT @StrokeAHA_ASA: #STROKE Simultaneous publication at #ESOC2025 🔴🔵 SUMMIT MAX trial showed that the super large bore HiPoint system was n…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 30 additional X posts.